SciAnda is committed to providing developmental services as well as supplying active pharmaceutical ingredients (APIs) of the highest quality and at competitive cost in both the generic market as well as for customers with patented products. Our current products are mainly small molecule and peptide APIs.
In order to increase our market share in this region, we have aggressively focused on the Chinese API market and have established strategic alliances with several Chinese pharmaceutical companies to assist them in the development of their products. In addition, we can provide OEM services for global pharmaceutical companies with products in China.
In addition to seeking local pharmaceutical partners intent on developing their products for the Chinese market, SciAnda can also assist these companies with their European, American, and Japanese registrations and filings. Sales and marketing in these regions would continue to be the responsibility of our customers.